Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate

Molecular Carcinogenesis

Volumn 20, Issue 2, 1997, Pages 162-167

  Angel, Joe M ^a   Beltrán, Linda ^a   Minda, Karolina ^a   Rupp, Tim ^a   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemical carcinogenesis; Genetics; Genome scan; Promotion susceptibility gene

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL CARCINOGENESIS; CHROMOSOME 9; CONTROLLED STUDY; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENS; CHROMOSOMES; COCARCINOGENESIS; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; LINKAGE (GENETICS); MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; MURINAE;

EID: 0030670515     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199710)20:2<162::AID-MC2>3.0.CO;2-P     Document Type: Article

References (21)

1. Perera FP. Molecular epidemiology: Insights into cancer susceptibility, risk assessment and prevention. J Natl Cancer Inst 88:496-509, 1996.
2. Boutwell RK. Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 4:207-250, 1964.
3. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63-128, 1992.
4. Naito M, DiGiovanni J. Genetic background and development of skin tumors. In: Conti CJ, Slaga TJ, Klein-Szanto AJP, (eds), Skin Tumors: Experimental and Clinical Aspects, Vol. 3. Raven Press, New York, 1989, pp. 187-212.
5. Slaga TJ. Mechanisms involved in two-stage carcinogenesis in mouse skin. In: Slaga, TJ, (ed), Mechanisms of Tumor Promotion, Vol. II. CRC Press, Florida, 1984, pp. 1-16.
6. Ashman LK, Murray AW, Cook MG, Kotlarski I. Two-stage skin carcinogenesis in sensitive and resistant mouse strains. Carcinogenesis 3:99-102, 1982.
7. DiGiovanni J, Slaga TJ, Boutwell RK. Comparison of the tumor-initiating activity of 7, 12-demethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CD-1 mice. Carcinogenesis 1:381-389, 1980.
8. DiGiovanni J, Prichett WP, Decina PC, Diamond L. DBA/2 mice are as sensitive as SENCAR mice to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 5: 1493-1498, 1984.
9. DiGiovanni J, Naito M, Chenicek KJ. Genetic factors controlling suseptibility to skin tumor promotion in mice. In: Barret JC, Langenbach E, Gilmore, E (eds), Tumor Promoters: Biological Approaches for Mechanistic Studies and Assay Systems. Raven Press, New York, 1987, pp. 51-69.
10. Reiners JJ Jr, Nesnow S, Slaga TJ. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis 5:301-307, 1984.
11. DiGiovanni J. Genetic determinants of cancer susceptibility. In: Sipes IG, McWueen CA, Gandolfi AJ (eds), Comprehensive Toxicology. Elsevier, New York, in press.
12. DiGiovanni J, Imamoto A, Naito M, et al. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis 13:525-531, 1992.
13. Naito M, Chenicek KJ, Naito Y, DiGiovanni, J. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 × DBA/ 2) F1 mice is inherited as an incomplete dominant trait: Evidence for multi-locus involvement. Carcinogenesis 9:639-645, 1988.
14. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet 10:424-429, 1995.
15. Dietrich W, Katz H, Lincoln SE, et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447, 1992.
16. Lee GH, Bennett LM, Carabeo RA, Drinkwater NR. Identification of hepatocarcinogenesis resistance genes in DBA/2 mice. Genetics 139:387-395, 1995.
17. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247, 1995.
18. Imai K. Mouse chromosome 9. Mamm Genome 6:S170-189, 1996.
19. Bonyadi M, Cui W, Nagase H, Akhurst RJ. The TGFβ type II receptor, Tgfbr2, maps to distal mouse chromosome 9. Genomics 33:328-329, 1996.
20. Kruglyak L, Lander ES. A nonparametric approach for mapping quantitative trait loci. Genetics 139:1421-1428, 1995.
21. Poole TM, Drinkwater NR. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc Natl Acad Sci USA 93: 5848-5853, 1996.